1.32
price down icon7.04%   -0.10
after-market After Hours: 1.40 0.08 +6.06%
loading

Phio Pharmaceuticals Corp Stock (PHIO) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
16.32%
2.209
1.899 2.776 2.547 3.602
Operating Income/Loss
16.32%
-2.209
-1.899 -2.776 -2.547 -3.602
Nonoperating Income/Loss
1,275%
0.055
0.004 -0.004 -0.002 -
Income/Loss From Continuing Operations Before Tax
13.67%
-2.154
-1.895 -2.78 -2.549 -3.602
Income/Loss From Continuing Operations After Tax
13.67%
-2.154
-1.895 -2.78 -2.549 -3.602
Net Income/Loss
13.67%
-2.154
-1.895 -2.78 -2.549 -3.602
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,385%
4.5801
0.3085 2.4402 1,728.49 1.1422
Diluted Average Shares
1,385%
4.5801
0.3085 2.4402 1,728.49 1.1422
Basic Earnings Per Share
176.47%
-0.47
-0.17 -1.14 -1.47 -3.15
Diluted Earnings Per Share
176.47%
-0.47
-0.17 -1.14 -1.47 -3.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$76.29
price down icon 6.45%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
$19.13
price down icon 7.54%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Cap:     |  Volume (24h):